Resistant hypertension affects twenty percent of all hypertensive patients. It is the source of much cardiovascular risk and its ultimate sequela. To this end innovative mechanisms of addressing this problem have and are being developed. One of these is renal denervation of the sympathetic system. Our guests on the podcast compare clinical studies and share success stories for treatment of resistant hypertensive patients.
Podden och tillhörande omslagsbild på den här sidan tillhör American Heart Association. Innehållet i podden är skapat av American Heart Association och inte av, eller tillsammans med, Poddtoppen.
